Colorado Newborn Blood Spot Screening (CONBSP)


Urgent Announcement

Test results and final reports for X-linked Adrenoleukodystrophy (X-ALD) from the Colorado State Public Health Laboratory are currently delayed.  First tier testing has a high rate of false positives and requires additional second tier testing. X-ALD does not require immediate medical follow-up. There has been a delay with the second tier testing, we are working with our external vendor to resolve the issue and thank you in advance for your patience.  

If you have any questions, contact Greg Bonn, Manager of the Newborn Blood spot Screening Program at 720-830-8992 or email gregory.bonn@state.co.us.



General announcements

Colorado’s Newborn Screening Panel

New disorders are coming soon to Colorado’s newborn screening panel!

On March 20, 2024, the Colorado Board of Health approved the addition of two disorders to the Colorado newborn screening panel for population screening:

  • Guanidinoacetate Methyltransferase (GAMT) Deficiency
  • Mucopolysaccharidosis Type II (MPS II)

Additionally, the Board approved targeted screening for congenital cytomegalovirus (cCMV) infection. 


The rules will go into effect May 15, 2024. Screening for these conditions will begin once instrument procurement and validation testing are completed, and contacts are established for follow-up services. Continue to check back for updates.

Transition to E-Reports

CONBSP will no longer send out physical mailers or fax the daily reports for the newborn screen to any health facilities. The only exception is mailing abnormal reports. Reports can still be requested by phone or fax by submitting a completed results request form. Prior to calling or faxing, check E-portal. If the report is unavailable, contact the birthing facility.

Sign up for an E-report account to access the portal to obtain newborn screen reports. 

If you are unable to access this document please contact cdphe_nbs_software@state.co.us.


Health care providers and laboratories

Abnormal Results | Education | Training | Quality Improvement (QI) | E-Report | Result Request | Corrections Request

Information for stakeholders

Meeting Schedule | Newsletter | Disorders | QI | Policies

Information for parents

Common Questions | Sickle Cell Information | Disorders 




Newborn Blood Spot Screening Phone: 303-692-3675 | Fax: 303-691-4008 | Email: cdphe_conbs@state.co.us